Matches in Wikidata for { <http://www.wikidata.org/entity/Q102373684> ?p ?o ?g. }
- Q102373684 description "2020 nî lūn-bûn" @default.
- Q102373684 description "2020 ވަނަ އަހަރުގެ ނޮވެމްބަރުމަހުގެ 24ވަނަ ދުވަހު ޝާއިރުކުރެވުނު ސައިންޓިފިކް ލިޔުމެއް" @default.
- Q102373684 description "2020年の論文" @default.
- Q102373684 description "2020年学术文章" @default.
- Q102373684 description "2020年学术文章" @default.
- Q102373684 description "2020年学术文章" @default.
- Q102373684 description "2020年学术文章" @default.
- Q102373684 description "2020年学术文章" @default.
- Q102373684 description "2020年学术文章" @default.
- Q102373684 description "2020年學術文章" @default.
- Q102373684 description "2020年學術文章" @default.
- Q102373684 description "2020年學術文章" @default.
- Q102373684 description "2020年學術文章" @default.
- Q102373684 description "2020年學術文章" @default.
- Q102373684 description "2020년 논문" @default.
- Q102373684 description "article científic" @default.
- Q102373684 description "article scientific" @default.
- Q102373684 description "article scientifique" @default.
- Q102373684 description "articol științific" @default.
- Q102373684 description "articolo scientifico" @default.
- Q102373684 description "artigo científico" @default.
- Q102373684 description "artigo científico" @default.
- Q102373684 description "artigo científico" @default.
- Q102373684 description "artikel ilmiah" @default.
- Q102373684 description "artikull shkencor" @default.
- Q102373684 description "artikulong pang-agham" @default.
- Q102373684 description "artykuł naukowy" @default.
- Q102373684 description "artículo científico publicado en 2020" @default.
- Q102373684 description "artículu científicu" @default.
- Q102373684 description "bilimsel makale" @default.
- Q102373684 description "bài báo khoa học" @default.
- Q102373684 description "naučni članak" @default.
- Q102373684 description "scienca artikolo" @default.
- Q102373684 description "scientific article published on 24 November 2020" @default.
- Q102373684 description "scientific article published on 24 November 2020" @default.
- Q102373684 description "scientific article published on 24 November 2020" @default.
- Q102373684 description "teaduslik artikkel" @default.
- Q102373684 description "tieteellinen artikkeli" @default.
- Q102373684 description "tudományos cikk" @default.
- Q102373684 description "vedecký článok" @default.
- Q102373684 description "vetenskaplig artikel" @default.
- Q102373684 description "videnskabelig artikel udgivet 24. november 2020" @default.
- Q102373684 description "vitenskapelig artikkel" @default.
- Q102373684 description "vitskapeleg artikkel" @default.
- Q102373684 description "vědecký článek" @default.
- Q102373684 description "wetenschappelijk artikel" @default.
- Q102373684 description "wissenschaftlicher Artikel" @default.
- Q102373684 description "επιστημονικό άρθρο" @default.
- Q102373684 description "мақолаи илмӣ" @default.
- Q102373684 description "наукова стаття, опублікована в листопаді 2020" @default.
- Q102373684 description "научна статия" @default.
- Q102373684 description "научная статья" @default.
- Q102373684 description "научни чланак" @default.
- Q102373684 description "научни чланак" @default.
- Q102373684 description "מאמר מדעי" @default.
- Q102373684 description "مقالة علمية نشرت في 24 نوفمبر 2020" @default.
- Q102373684 description "২৪ নভেম্বর ২০২০-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q102373684 description "บทความทางวิทยาศาสตร์" @default.
- Q102373684 description "სამეცნიერო სტატია" @default.
- Q102373684 name "An unfavourable outcome following switching intravenous abatacept and tocilizumab to subcutaneous forms during the COVID-19 pandemic" @default.
- Q102373684 name "An unfavourable outcome following switching intravenous abatacept and tocilizumab to subcutaneous forms during the COVID-19 pandemic" @default.
- Q102373684 name "An unfavourable outcome following switching intravenous abatacept and tocilizumab to subcutaneous forms during the COVID-19 pandemic" @default.
- Q102373684 type Item @default.
- Q102373684 label "An unfavourable outcome following switching intravenous abatacept and tocilizumab to subcutaneous forms during the COVID-19 pandemic" @default.
- Q102373684 label "An unfavourable outcome following switching intravenous abatacept and tocilizumab to subcutaneous forms during the COVID-19 pandemic" @default.
- Q102373684 label "An unfavourable outcome following switching intravenous abatacept and tocilizumab to subcutaneous forms during the COVID-19 pandemic" @default.
- Q102373684 prefLabel "An unfavourable outcome following switching intravenous abatacept and tocilizumab to subcutaneous forms during the COVID-19 pandemic" @default.
- Q102373684 prefLabel "An unfavourable outcome following switching intravenous abatacept and tocilizumab to subcutaneous forms during the COVID-19 pandemic" @default.
- Q102373684 prefLabel "An unfavourable outcome following switching intravenous abatacept and tocilizumab to subcutaneous forms during the COVID-19 pandemic" @default.
- Q102373684 P1433 Q102373684-FF02B4A5-7AFB-4FC9-B7A0-AE1F9000F462 @default.
- Q102373684 P1476 Q102373684-5D2B659F-525D-49BD-9B26-65499DEEB0DD @default.
- Q102373684 P2093 Q102373684-05A3381D-873B-494B-BC11-47147CB60601 @default.
- Q102373684 P2093 Q102373684-8585BBF2-852C-4449-B13B-177D8FC39A3E @default.
- Q102373684 P2093 Q102373684-B411ECA9-7689-4B70-814D-E361D678B025 @default.
- Q102373684 P2093 Q102373684-B6FF8707-8322-43FC-B618-9EBCBAF89615 @default.
- Q102373684 P2093 Q102373684-C0386FF0-E31E-47A9-99CE-345F61AC532E @default.
- Q102373684 P31 Q102373684-C14C1DD6-6FA2-461E-A78F-793B23B5D017 @default.
- Q102373684 P356 Q102373684-DB8AFA56-960D-4E1E-92FB-5041E4D51835 @default.
- Q102373684 P577 Q102373684-81707752-D518-474C-BAD5-4F869F69B064 @default.
- Q102373684 P698 Q102373684-574A4929-03DB-479B-852E-674FC1F3A859 @default.
- Q102373684 P921 Q102373684-370DF375-0A35-4987-A7E7-4A48F8956CDB @default.
- Q102373684 P921 Q102373684-6C38A38D-15E6-42E5-B4D7-F0B4B456164D @default.
- Q102373684 P921 Q102373684-9AFD2FA3-9A3B-4E13-BE73-55105B8B8168 @default.
- Q102373684 P932 Q102373684-7491801A-B2BA-418E-B6BC-487984E91099 @default.
- Q102373684 P356 KEAA653 @default.
- Q102373684 P698 33232489 @default.
- Q102373684 P1433 Q7320492 @default.
- Q102373684 P1476 "An unfavourable outcome following switching intravenous abatacept and tocilizumab to subcutaneous forms during the COVID-19 pandemic" @default.
- Q102373684 P2093 "Michael R Ehrenstein" @default.
- Q102373684 P2093 "Muhammad Shipa" @default.
- Q102373684 P2093 "Pauline Buck" @default.
- Q102373684 P2093 "Rishi Gupta" @default.
- Q102373684 P2093 "Su-Ann Yeoh" @default.
- Q102373684 P31 Q13442814 @default.
- Q102373684 P356 "10.1093/RHEUMATOLOGY/KEAA653" @default.
- Q102373684 P577 "2020-11-24T00:00:00Z" @default.
- Q102373684 P698 "33232489" @default.
- Q102373684 P921 Q425154 @default.
- Q102373684 P921 Q81068910 @default.
- Q102373684 P921 Q84263196 @default.